Carl Horn, Founder
Carl Horn brings over 25 years of pharmaceutical, diagnostic and biotech experience to JBI. Prior to JBI, he served as Senior Vice President, Corporate and Business Affairs at Therapeutic Proteins International, LLC (TPI). At TPI, Carl successfully guided the company through its acquisition by Amneal Enterprises, LLC. Prior to TPI, Carl was General Manager Global Export Business for Takeda International. Prior to Takeda, Carl led the business development function at TAP Pharmaceuticals for seven years. Previously, Carl worked at Abbott Laboratories Diagnostics and Pharmaceutical Divisions in marketing and strategic planning leadership positions. Mr. Horn received his MS degree in statistics from the University of Wisconsin – Milwaukee.
Deborah Milkowski, PHD, Founder, CSO
Dr. Milkowski has more than 13 years of industry experience in senior roles at TAP Pharmaceuticals where she was the Director of the Pharmacology and Technical Assessment organizations. Dr. Milkowski oversaw the pharmacology sections of 10 IND and 4 NDA submissions, including approvals for Lupron Depot® and Uloric®. She was responsible for the safety and efficacy pharmacology for all development compounds as well as for the technical feasibility assessment of all in-licensed technology. Dr. Milkowski received her PhD in Molecular Biology and Biochemistry from Northwestern University Medical School.